tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RGEN Stock Latest News

Repligen price target lowered to $150 from $170 at Canaccord
The FlyRepligen price target lowered to $150 from $170 at Canaccord
8d ago
RGEN
Repligen price target lowered to $202 from $219 at RBC Capital
PremiumThe Fly
Repligen price target lowered to $202 from $219 at RBC Capital
16d ago
RGEN
Repligen appoints Jacob Johnson as VP, investor relations
PremiumThe Fly
Repligen appoints Jacob Johnson as VP, investor relations
16d ago
RGEN
Promising Outlook for Repligen: Strong Order Momentum, Strategic Positioning, and Growth Opportunities
PremiumRatings
Promising Outlook for Repligen: Strong Order Momentum, Strategic Positioning, and Growth Opportunities
24d ago
RGEN
Repligen initiated with an In Line at Evercore ISI
PremiumThe Fly
Repligen initiated with an In Line at Evercore ISI
1M ago
RGEN
Repligen’s Strategic Acquisition of 908 Devices’ Assets: A Buy Rating for Long-term Shareholder Value
PremiumRatingsRepligen’s Strategic Acquisition of 908 Devices’ Assets: A Buy Rating for Long-term Shareholder Value
2M ago
RGEN
Repligen’s Strategic Acquisition: Hold Rating Amid Short-term Financial Dilution and Long-term Growth Potential
Premium
Ratings
Repligen’s Strategic Acquisition: Hold Rating Amid Short-term Financial Dilution and Long-term Growth Potential
2M ago
RGEN
Repligen deal can expand bioprocessing opportunities, says RBC Capital
Premium
The Fly
Repligen deal can expand bioprocessing opportunities, says RBC Capital
2M ago
MASS
RGEN
Repligen’s Strategic Acquisition of 908 Devices’ Bioprocessing Assets Boosts Buy Rating
PremiumRatings
Repligen’s Strategic Acquisition of 908 Devices’ Bioprocessing Assets Boosts Buy Rating
2M ago
RGEN
Repligen acquires bioprocessing analytic portfolio from 908 Devices for $70M
PremiumThe Fly
Repligen acquires bioprocessing analytic portfolio from 908 Devices for $70M
2M ago
MASS
RGEN
Repligen purchases 908 Devices’ bioprocessng analytics portfolio for $70M
PremiumThe Fly
Repligen purchases 908 Devices’ bioprocessng analytics portfolio for $70M
2M ago
MASS
RGEN
Repligen Delays 2024 Yearly Report Filing
PremiumCompany Announcements
Repligen Delays 2024 Yearly Report Filing
2M ago
RGEN
Buy Recommendation for Repligen Driven by Strong Performance and Positive Growth Outlook
PremiumRatingsBuy Recommendation for Repligen Driven by Strong Performance and Positive Growth Outlook
2M ago
RGEN
Repligen’s Earnings Call: Growth Amid Challenges
Premium
Company Announcements
Repligen’s Earnings Call: Growth Amid Challenges
2M ago
RGEN
Repligen: Strong Market Position and Growth Potential Justify Buy Rating
Premium
Ratings
Repligen: Strong Market Position and Growth Potential Justify Buy Rating
2M ago
RGEN
Repligen price target raised to $170 from $165 at Canaccord
PremiumThe Fly
Repligen price target raised to $170 from $165 at Canaccord
2M ago
RGEN
Repligen Corporation Announces 2024 Financial Results
PremiumCompany Announcements
Repligen Corporation Announces 2024 Financial Results
2M ago
RGEN
Hold Rating for Repligen Amid Mixed Performance and Modest Growth Projections
PremiumRatings
Hold Rating for Repligen Amid Mixed Performance and Modest Growth Projections
2M ago
RGEN
Repligen price target raised to $165 from $160 at Jefferies
PremiumThe Fly
Repligen price target raised to $165 from $160 at Jefferies
2M ago
RGEN
Repligen’s Strong Market Position and Growth Potential: A Buy Recommendation
PremiumRatingsRepligen’s Strong Market Position and Growth Potential: A Buy Recommendation
2M ago
RGEN
Repligen reports Q4 adjusted EPS 44c, consensus 41c
Premium
The Fly
Repligen reports Q4 adjusted EPS 44c, consensus 41c
2M ago
RGEN
Repligen sees FY25 non-GAAP EPS $1.67-$1.76, consensus $1.71
Premium
The Fly
Repligen sees FY25 non-GAAP EPS $1.67-$1.76, consensus $1.71
2M ago
RGEN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >